Zeng Hua-Ping, Chen Hong, Chen Dan, Ma Guo-Ping, Zhu Xian-Mu, Liu Xiu-Mian, Hong Li-Ting
Institute of Senile Disease,Fujian Provincial Hospital Cadre Special Clinic Fuzhou 350001,China Department of Pharmacy,Fujian University of Traditional Chinese Medicine Fuzhou 350122,China.
Institute of Senile Disease,Fujian Provincial Hospital Cadre Special Clinic Fuzhou 350001,China.
Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(4):819-826. doi: 10.19540/j.cnki.cjcmm.20181129.007.
The paper studies and compares the metabolic difference of active ingredients of lipid-lowering flavonoid extract of Daidai in rat livers and intestinal microsomes,in order to explore the phase Ⅰ metabolism characteristics of active ingredients in livers and intestines. UPLC-MS/MS was used to establish a quantitative analysis method for active ingredients,neohesperidin and narngin,in a phase Ⅰ metabolism incubation system of liver and intestinal microsomes. Differential centrifugation was used to make liver and intestinal microsomes of rats. A phase Ⅰ metabolism incubation system was established,and the concentrations of the residual at different incubation time points were analyzed. Graphs were plotted to calculate the metabolic elimination half-life of the main active parts,with the natural logarithm residual percentage values ln( X) at different time points as the y axis,and time t as the x axis. The metabolism characteristics of the active ingredients were compared. The established UPLC-MS/MS quantitative analysis method has a good specialization,standard curve and linear range,accuracy and precision,with a satisfactory lower quantitative limit. The method allows quantitative detection of the active ingredients in a phase Ⅰ metabolism incubation system of liver and intestinal microsomes of rats. In the rats liver microsomes incubation system,the metabolic elimination half-life of neohesperidin and narngin were( 2. 20 ± 0. 28) h and( 1. 97±0. 28) h respectively. The elimination half-life of neohesperidin was larger than that of narngin,but with no statistically significant difference. In the rats intestinal microsomes incubation system,the metabolic elimination half-lives of neohesperidin and narngin were( 3. 68±0. 54) h and( 2. 26±0. 13) h respectively. The elimination half-life of neohesperidin was larger than that of narngin,with statistically significant differences( P<0. 05). The elimination half-lives of the active ingredients in liver microsomes were smaller than those in intestinal microsomes. The experiment results showed that the active ingredients of lipid-lowering flavonoid extract of Daidai had different elimination half-lives in phase Ⅰ rats liver and intestinal microsomes incubation system. This implied that they had different metabolic characteristics in rats liver and intestine,and liver may be the main metabolism site of the active ingredients. The phaseⅠ metabolism of narngin was stronger than that of neohesperidin. The differences between their metabolic characteristics may be related to the binding sites of B-ring hydroxyl in flavonoid glycosides and the number of methoxyl group. The results provided an important experimental basis for further development and clinical application of lipid-lowering flavonoid extract preparation of Daidai.
本文研究并比较了代代降脂黄酮提取物活性成分在大鼠肝脏和肠道微粒体中的代谢差异,以探讨活性成分在肝脏和肠道中的Ⅰ相代谢特征。采用超高效液相色谱-串联质谱法(UPLC-MS/MS)建立了在肝脏和肠道微粒体Ⅰ相代谢孵育体系中活性成分新橙皮苷和柚皮苷的定量分析方法。采用差速离心法制备大鼠肝脏和肠道微粒体。建立Ⅰ相代谢孵育体系,分析不同孵育时间点的剩余浓度。绘制曲线,以不同时间点的自然对数剩余百分比值ln(X)为纵坐标,时间t为横坐标,计算主要活性成分的代谢消除半衰期。比较活性成分的代谢特征。所建立的UPLC-MS/MS定量分析方法具有良好的专属性、标准曲线、线性范围、准确度和精密度,定量下限令人满意。该方法可对大鼠肝脏和肠道微粒体Ⅰ相代谢孵育体系中的活性成分进行定量检测。在大鼠肝脏微粒体孵育体系中,新橙皮苷和柚皮苷的代谢消除半衰期分别为(2.20±0.28)h和(1.97±0.28)h。新橙皮苷的消除半衰期大于柚皮苷,但差异无统计学意义。在大鼠肠道微粒体孵育体系中,新橙皮苷和柚皮苷的代谢消除半衰期分别为(3.68±0.54)h和(2.26±0.13)h。新橙皮苷的消除半衰期大于柚皮苷,差异有统计学意义(P<0.05)。活性成分在肝脏微粒体中的消除半衰期小于在肠道微粒体中的消除半衰期。实验结果表明,代代降脂黄酮提取物活性成分在大鼠肝脏和肠道微粒体Ⅰ相孵育体系中的消除半衰期不同。这表明它们在大鼠肝脏和肠道中的代谢特征不同,肝脏可能是活性成分的主要代谢部位。柚皮苷的Ⅰ相代谢强于新橙皮苷。它们代谢特征的差异可能与黄酮苷中B环羟基的结合位点和甲氧基的数量有关。研究结果为代代降脂黄酮提取物制剂的进一步开发和临床应用提供了重要的实验依据。